Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH) announced that its subsidiary, Prinston Pharmaceutical Co., Ltd., has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules. Gabapentin Capsules are primarily used to treat postherpetic neuralgia in adults.